collection
Collections Culture of Addiction: socioeco...

Culture of Addiction: socioeconomic patterns USA

https://read.qxmd.com/read/36292717/the-pharmacogenetics-of-cannabis-in-the-treatment-of-chronic-pain
#1
JOURNAL ARTICLE
Paolo Poli, Luana Peruzzi, Pierdomenico Maurizi, Antonella Mencucci, Antonella Scocca, Simona Carnevale, Ottavia Spiga, Annalisa Santucci
BACKGROUND: The increase in the medical use of cannabis has revealed a number of beneficial effects, a variety of adverse side effects and great inter-individual variability. Association studies connecting consumption, addiction and side effects related to recreational cannabis use have led to the identification of several polymorphic genes that may play a role in the pharmacodynamics and pharmacokinetics of cannabis. METHOD: In total, 600 patients treated with cannabis were genotyped for several candidate polymorphic genes (single-nucleotide polymorphism; SNP), encoding receptors CNR1 and TRPV1; for the ABCB1 transporter; for biotransformation, bioactivation and biosynthesis; and CYP3A4, COMT and UGT2B7 conjugation...
October 11, 2022: Genes
https://read.qxmd.com/read/36287740/the-potential-addictive-mechanism-involved-in-repetitive-nonsuicidal-self-injury-the-roles-of-emotion-dysregulation-and-impulsivity-in-adolescents
#2
JOURNAL ARTICLE
Jinmeng Liu, Yemiao Gao, Chunxi Liang, Xia Liu
BACKGROUND AND AIMS: Nonsuicidal self-injury (NSSI) is highly prevalent in adolescents and is associated with various mental health problems. Repetitive NSSI (R-NSSI), as an extreme manifestation of NSSI, is a growing concern and has been proposed as a behavioral addiction. However, little is known about the potential addictive mechanisms of NSSI. This study aimed to examine the mediating effect of emotion dysregulation and the moderating effect of impulsivity using the Interaction of Person-Affect-Cognition-Execution (I-PACE) model in adolescents who repeatedly engage in NSSI...
December 27, 2022: Journal of Behavioral Addictions
https://read.qxmd.com/read/36282967/successful-buprenorphine-transition-while-overlapping-with-a-full-opioid-agonist-to-treat-chronic-pain-a-case-report
#3
Kishan V Patel, Sidharth Sahni, Lanvin F Taylor
Buprenorphine is a partial mu opioid agonist that has been increasingly utilized to treat patients with chronic pain and opioid use disorder (OUD). The drug has proven to provide significant chronic pain relief at low doses ranging from 75 to 1800 mcg. The conventional buprenorphine transitional process delays its introduction until patients begin withdrawal. However, this process can pose a barrier to both patients and providers due to some patients' inability to tolerate traditional prerequisite withdrawal...
January 1, 2023: Journal of osteopathic medicine
https://read.qxmd.com/read/36283655/green-light-exposure-elicits-anti-inflammation-endogenous-opioid-release-and-dampens-synaptic-potentiation-to-relieve-post-surgical-pain
#4
JOURNAL ARTICLE
Laurent F Martin, Kevin Cheng, Stephanie M Washington, Millie Denton, Vasudha Goel, Maithili Khandekar, Tally M Largent-Milnes, Amol Patwardhan, Mohab M Ibrahim
Light therapy improves multiple conditions such as seasonal affective disorders, circadian rhythm dysregulations, and neurodegenerative diseases. However, little is known about its potential benefits in pain management. While current pharmacologic methods are effective in many cases, the associated side effects can limit their use. Non-pharmacological methods would minimize drug dependence, facilitating a reduction of the opioid burden. Green light therapy has been shown to be effective in reducing chronic pain in humans and rodents...
March 2023: Journal of Pain
https://read.qxmd.com/read/36253965/does-the-concept-of-ultra-processed-foods-help-inform-dietary-guidelines-beyond-conventional-classification-systems-debate-consensus
#5
EDITORIAL
Arne Astrup, Carlos A Monteiro
The participants in this debate agree that food processing vitally affects human health, and that the extent of food processing significantly affects diet quality and health outcomes. They disagree on the significance of ultra-processing, as defined within the Nova food classification system. The YES position holds that the concept is well-founded, clear, and supported by a wealth of investigations, as demonstrated by systematic association between ultra-processed food (UPF) intake and various diseases and disorders, and the persistence of these associations with control for critical nutrients...
December 19, 2022: American Journal of Clinical Nutrition
https://read.qxmd.com/read/36264281/vitamin-b-6-and-riboflavin-their-metabolic-interaction-and-relationship-with-mthfr-genotype-in-adults-aged-18-102-years
#6
JOURNAL ARTICLE
Harry Jarrett, Helene McNulty, Catherine F Hughes, Kristina Pentieva, J J Strain, Adrian McCann, Liadhan McAnena, Conal Cunningham, Anne M Molloy, Albert Flynn, Sinead M Hopkins, Geraldine Horigan, Ciara O'Connor, Janette Walton, Breige A McNulty, Michael J Gibney, Yvonne Lamers, Mary Ward
BACKGROUND: The generation of the active form of vitamin B-6, pyridoxal 5'-phosphate (PLP), in tissues is dependent upon riboflavin as flavin mononucleotide, but whether this interaction is important for maintaining vitamin B-6 status is unclear. OBJECTIVE: To investigate vitamin B-6 and riboflavin status, their metabolic interaction, and relationship with methylenetetrahydrofolate reductase (MTHFR) genotype in adulthood. METHODS: Data from 5612 adults aged 18-102 y were drawn from the Irish National Adult Nutrition Survey (NANS; population-based sample) and the Trinity-Ulster Department of Agriculture (TUDA) and Genovit cohorts (volunteer samples)...
December 19, 2022: American Journal of Clinical Nutrition
https://read.qxmd.com/read/36121359/physician-response-to-covid-19-driven-telehealth-flexibility-for-opioid-use-disorder
#7
JOURNAL ARTICLE
Tamara Beetham, David A Fiellin, Susan H Busch
OBJECTIVES: To learn how preferences and practices regarding telehealth have evolved during the COVID-19 pandemic for physicians who provide opioid use disorder (OUD) treatment. STUDY DESIGN: Publicly registered physicians who provide OUD treatment were surveyed on their current and retrospective use of telehealth and how their perception of telehealth effectiveness and policy preferences have changed during the COVID-19 pandemic as telehealth regulations were loosened throughout the country...
September 2022: American Journal of Managed Care
https://read.qxmd.com/read/30650522/online-porn-addiction-what-we-know-and-what-we-don-t-a-systematic-review
#8
REVIEW
Rubén de Alarcón, Javier I de la Iglesia, Nerea M Casado, Angel L Montejo
In the last few years, there has been a wave of articles related to behavioral addictions; some of them have a focus on online pornography addiction. However, despite all efforts, we are still unable to profile when engaging in this behavior becomes pathological. Common problems include: sample bias, the search for diagnostic instrumentals, opposing approximations to the matter, and the fact that this entity may be encompassed inside a greater pathology (i.e., sex addiction) that may present itself with very diverse symptomatology...
January 15, 2019: Journal of Clinical Medicine
https://read.qxmd.com/read/36195895/factors-that-distinguish-opioid-withdrawal-during-induction-with-buprenorphine-microdosing-a-configurational-analysis
#9
JOURNAL ARTICLE
Adams K K, Miech E J, Sobieraj D M
BACKGROUND: Novel buprenorphine dosing strategies have emerged with an aim to transition patients from opioid agonists to buprenorphine without prerequisite opioid withdrawal. We applied a configurational approach to a subset of data from our earlier systematic review to answer the following question: when patients received a buprenorphine initiation strategy aimed to eliminate prerequisite withdrawal, what factors consistently distinguished patients that experienced withdrawal during the initiation process from patients that did not? METHODS: From the 24 cases identified by our systematic review, we included cases that were treated using buprenorphine microdosing strategies (oral or transdermal), cases with opioid use disorder, and cases that fully transitioned to buprenorphine without continuing the full opioid agonist...
October 4, 2022: Addiction Science & Clinical Practice
https://read.qxmd.com/read/32774804/thymoquinone-from-nigella-sativa-to-a-protective-pharmacological-compound-in-managing-opioid-dependence-and-amphetamine-type-stimulant-issues
#10
REVIEW
Liyana Hazwani Mohd Adnan, Nor Hidayah Abu Bakar, Nordin Simbak, Nasir Mohamad, Rusli Ismail, Nor Zidah Ahmad, Nor Suliana Mustafa, Nurul Farah Aina Md Fauzi
Opioids, amphetamines, and other types of substances have been widely abused around the world. Opioid dependence and tolerance are two distinct phenomena that have been associated with substance abuse issues. The management of its adverse consequences is becoming more challenging. More and more people are treated in Methadone Maintenance Therapy (MMT) program yet the issues are still unresolved. Researchers are continuing to study the best formulation in treating opioid dependent people starting with modern and alternative drug therapies...
July 2020: Iranian Journal of Basic Medical Sciences
https://read.qxmd.com/read/25371514/bad-bugs-need-old-drugs-a-stewardship-program-s-evaluation-of-minocycline-for-multidrug-resistant-acinetobacter-baumannii-infections
#11
JOURNAL ARTICLE
Debra A Goff, Karri A Bauer, Julie E Mangino
BACKGROUND: Minocycline is an "old-drug" with Food and Drug Administration approval for the treatment of infection due to Acinetobacter species. The purpose of this study is to describe an Antimicrobial Stewardship Program's evaluation of minocycline for the treatment of patients with multidrug resistant A. baumannii (MDR-AB) infections. METHODS: This study evaluated hospitalized adult patients (September 2010 through March 2013) who received minocycline intravenously (IV) for a MDR-AB infection...
December 1, 2014: Clinical Infectious Diseases
https://read.qxmd.com/read/36232883/crotalphine-modulates-microglia-m1-m2-phenotypes-and-induces-spinal-analgesia-mediated-by-opioid-cannabinoid-systems
#12
JOURNAL ARTICLE
Flavia S R Lopes, Aline C Giardini, Morena B Sant'Anna, Louise F Kimura, Michelle C Bufalo, Hugo Vigerelli, Vanessa O Zambelli, Gisele Picolo
Pain is a worldwide public health problem and its treatment is still a challenge since clinically available drugs do not completely reverse chronic painful states or induce undesirable effects. Crotalphine is a 14 amino acids synthetic peptide that induces a potent and long-lasting analgesic effect on acute and chronic pain models, peripherally mediated by the endogenous release of dynorphin A and the desensitization of the transient receptor potential ankyrin 1 (TRPA1) receptor. However, the effects of crotalphine on the central nervous system (CNS) and the signaling pathway have not been investigated...
September 30, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36041967/mitochondrial-dna-is-a-major-source-of-driver-mutations-in-cancer
#13
REVIEW
Minsoo Kim, Mahnoor Mahmood, Ed Reznik, Payam A Gammage
Mitochondrial DNA (mtDNA) mutations are among the most common genetic events in all tumors and directly impact metabolic homeostasis. Despite the central role mitochondria play in energy metabolism and cellular physiology, the role of mutations in the mitochondrial genomes of tumors has been contentious. Until recently, genomic and functional studies of mtDNA variants were impeded by a lack of adequate tumor mtDNA sequencing data and available methods for mitochondrial genome engineering. These barriers and a conceptual fog surrounding the functional impact of mtDNA mutations in tumors have begun to lift, revealing a path to understanding the role of this essential metabolic genome in cancer initiation and progression...
December 2022: Trends in Cancer
https://read.qxmd.com/read/28187288/emerging-biological-principles-of-metastasis
#14
REVIEW
Arthur W Lambert, Diwakar R Pattabiraman, Robert A Weinberg
Metastases account for the great majority of cancer-associated deaths, yet this complex process remains the least understood aspect of cancer biology. As the body of research concerning metastasis continues to grow at a rapid rate, the biological programs that underlie the dissemination and metastatic outgrowth of cancer cells are beginning to come into view. In this review we summarize the cellular and molecular mechanisms involved in metastasis, with a focus on carcinomas where the most is known, and we highlight the general principles of metastasis that have begun to emerge...
February 9, 2017: Cell
https://read.qxmd.com/read/31109201/efficacy-and-safety-of-flexibly-dosed-esketamine-nasal-spray-combined-with-a-newly-initiated-oral-antidepressant-in-treatment-resistant-depression-a-randomized-double-blind-active-controlled-study
#15
RANDOMIZED CONTROLLED TRIAL
Vanina Popova, Ella J Daly, Madhukar Trivedi, Kimberly Cooper, Rosanne Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E Thase, Richard C Shelton, Patricio Molero, Eduard Vieta, Malek Bajbouj, Husseini Manji, Wayne C Drevets, Jaskaran B Singh
OBJECTIVE: About one-third of patients with depression fail to achieve remission despite treatment with multiple antidepressants. This study compared the efficacy and safety of switching patients with treatment-resistant depression from an ineffective antidepressant to flexibly dosed esketamine nasal spray plus a newly initiated antidepressant or to a newly initiated antidepressant (active comparator) plus placebo nasal spray. METHODS: This was a phase 3, double-blind, active-controlled, multicenter study conducted at 39 outpatient referral centers...
June 1, 2019: American Journal of Psychiatry
https://read.qxmd.com/read/31421635/maintenance-of-antidepressant-and-antisuicidal-effects-by-d-cycloserine-among-patients-with-treatment-resistant-depression-who-responded-to-low-dose-ketamine-infusion-a-double-blind-randomized-placebo-control-study
#16
RANDOMIZED CONTROLLED TRIAL
Mu-Hong Chen, Chih-Ming Cheng, Ralitza Gueorguieva, Wei-Chen Lin, Cheng-Ta Li, Chen-Jee Hong, Pei-Chi Tu, Ya-Mei Bai, Shih-Jen Tsai, John H Krystal, Tung-Ping Su
Increasing evidence supports a rapid antidepressant and antisuicidal effect of a single subanesthetic dose of ketamine infusion for treatment-resistant depression (TRD). Maintaining the initial clinical response after ketamine infusion in TRD is a crucial next-step challenge. D-cycloserine (DCS), a partial agonist of the glycine co-agonist of the N-methyl-D-aspartate (NMDA) glutamate receptor, is potentially effective as a depression augmentation treatment. However, whether DCS maintains the antidepressant and antisuicidal effects of ketamine infusion remains unknown...
November 2019: Neuropsychopharmacology
https://read.qxmd.com/read/30283029/double-blind-placebo-controlled-dose-ranging-trial-of-intravenous-ketamine-as-adjunctive-therapy-in-treatment-resistant-depression-trd
#17
JOURNAL ARTICLE
Maurizio Fava, Marlene P Freeman, Martina Flynn, Heidi Judge, Bettina B Hoeppner, Cristina Cusin, Dawn F Ionescu, Sanjay J Mathew, Lee C Chang, Dan V Iosifescu, James Murrough, Charles Debattista, Alan F Schatzberg, Madhukar H Trivedi, Manish K Jha, Gerard Sanacora, Samuel T Wilkinson, George I Papakostas
Numerous placebo-controlled studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to induce rapid (within hours), transient antidepressant effects when administered intravenously (IV) at subanesthetic doses (0.5 mg/kg over 40 min). However, the optimal antidepressant dose remains unknown. We aimed to compare to active placebo the rapid acting antidepressant properties of a broad range of subanesthetic doses of IV ketamine among outpatients with treatment-resistant depression (TRD)...
July 2020: Molecular Psychiatry
https://read.qxmd.com/read/33653121/efficacy-of-intravenous-ketamine-in-adolescent-treatment-resistant-depression-a-randomized-midazolam-controlled-trial
#18
RANDOMIZED CONTROLLED TRIAL
Jennifer B Dwyer, Angeli Landeros-Weisenberger, Jessica A Johnson, Amalia Londono Tobon, José M Flores, Madeeha Nasir, Kevin Couloures, Gerard Sanacora, Michael H Bloch
OBJECTIVE: Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine's safety and efficacy in adolescents. METHODS: In this proof-of-concept randomized, double-blind, single-dose crossover clinical trial, 17 adolescents (ages 13-17) with a diagnosis of major depressive disorder received a single intravenous infusion of either ketamine (0...
April 1, 2021: American Journal of Psychiatry
https://read.qxmd.com/read/30922101/single-repeated-and-maintenance-ketamine-infusions-for-treatment-resistant-depression-a-randomized-controlled-trial
#19
RANDOMIZED CONTROLLED TRIAL
Jennifer L Phillips, Sandhaya Norris, Jeanne Talbot, Meagan Birmingham, Taylor Hatchard, Abigail Ortiz, Olabisi Owoeye, Lisa A Batten, Pierre Blier
OBJECTIVE: Subanesthetic ketamine doses have been shown to have rapid yet transient antidepressant effects in patients with treatment-resistant depression, which may be prolonged by repeated administration. The purpose of this study was to evaluate the antidepressant effects of a single ketamine infusion, a series of repeated ketamine infusions, and prolongation of response with maintenance infusions. METHODS: Forty-one participants with treatment-resistant depression completed a single-site randomized double-blind crossover comparison of single infusions of ketamine and midazolam (an active placebo control)...
May 1, 2019: American Journal of Psychiatry
https://read.qxmd.com/read/33397139/a-randomized-controlled-trial-of-repeated-ketamine-administration-for-chronic-posttraumatic-stress-disorder
#20
RANDOMIZED CONTROLLED TRIAL
Adriana Feder, Sara Costi, Sarah B Rutter, Abigail B Collins, Usha Govindarajulu, Manish K Jha, Sarah R Horn, Marin Kautz, Morgan Corniquel, Katherine A Collins, Laura Bevilacqua, Andrew M Glasgow, Jess Brallier, Robert H Pietrzak, James W Murrough, Dennis S Charney
OBJECTIVE: Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. The authors' previous proof-of-concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion. The present study is the first randomized controlled trial to test the efficacy and safety of repeated intravenous ketamine infusions for the treatment of chronic PTSD...
February 1, 2021: American Journal of Psychiatry
label_collection
label_collection
16818
1
2
2022-10-15 08:49:59
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.